Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents

Julio Licinio, Mauricio Arcos-Burgos, Sha Liu, Jorge Velez, Bernhard T. Baune, M. C. Jawahar, Volker Arolt, U. Dannlowski, Aaron Chuah, Gavin A. Huttley, Rhys Fogarty, Martin Lewis, Stefan Bornstein, Ma-Li Wong

Research output: Contribution to conferencePoster

Abstract

Background: Major depressive disorder (MDD) is a gene-environment disorder that affects approximately 350 million people worldwide. However, its under- lying genetic basis remains largely unknown. In this study, we investigated the role of functional genetic variants in MDD.

Methods: Whole-genome screening of functional variants were investigated in two cohorts: A discovery Los Angeles Mexican-American cohort (196 controls, 203 MDD) and a replication European-ancestry cohort (499 controls, 473 MDD). Controls had either high levels of stress (Mexican-American controls were primarily recent immi- grants) or high stress levels were given higher weights in our analysis (European-ancestry controls stress levels were accessed by questionnaires). Genome-wide association study (GWAS) and rare variant (regression- and permutation-based kernel-based adaptive cluster, KBAC) analyses were performed. Whole-genome sequencing and analyses were obtained in small subset of both cohorts. Pathway and network analyses were performed. Brain expression quantitative trait loci (eQTL) were extracted from the UK Brain Expression Consortium (UKBEC), and an animal model of chronic restraint stress was used to obtain behavioral, quantitative RT-PCR and Western blot data.
Results: In the Mexican-American cohort, we identified 44 common and rare functional variants associated to mild to moderate MDD. Pathway analysis disclosed that over- represented gene ontology processes included innate im- mune response, glutamate receptor signalling and detection of smell sensory perception. We replicated the PHF21B gene in the ethnically unrelated European-ancestry cohort. PHF21B variants contributed significantly to the levels of expression of this gene in the hippocampus and other brain areas. We will present new animal behavioral, molecular biology and biochemical data showing decreased hippocampal Phf21b gene and PHF21B protein express- ion in depressive-like behavior induced by chronic restraint stress.

Conference

ConferenceAmerican College of Neuropsychopharmacology (ACNP) 56th Annual Meeting
CountryUnited States
CityPalm Desert
Period3/12/177/12/17
OtherAmerican College of Neuropsychopharmacology (ACNP) 56th Annual Meeting is organized by American College of Neuropsychopharmacology (ACNP) and would be held during JW Marriott Desert Springs Resort and Spa, Palm Desert, California, United States Of America. This cme conference has been approved with a maximum of 33.5 AMA PRA Category 1 Credits.
Internet address

Cite this

Licinio, J., Arcos-Burgos, M., Liu, S., Velez, J., Baune, B. T., Jawahar, M. C., ... Wong, M-L. (2017). Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents. S549. Poster session presented at American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Desert, United States.
Licinio, Julio ; Arcos-Burgos, Mauricio ; Liu, Sha ; Velez, Jorge ; Baune, Bernhard T. ; Jawahar, M. C. ; Arolt, Volker ; Dannlowski, U. ; Chuah, Aaron ; Huttley, Gavin A. ; Fogarty, Rhys ; Lewis, Martin ; Bornstein, Stefan ; Wong, Ma-Li. / Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents. Poster session presented at American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Desert, United States.1 p.
@conference{f78bf04527cd4dd9bbf25a38a8d78f44,
title = "Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents",
abstract = "Background: Major depressive disorder (MDD) is a gene-environment disorder that affects approximately 350 million people worldwide. However, its under- lying genetic basis remains largely unknown. In this study, we investigated the role of functional genetic variants in MDD.Methods: Whole-genome screening of functional variants were investigated in two cohorts: A discovery Los Angeles Mexican-American cohort (196 controls, 203 MDD) and a replication European-ancestry cohort (499 controls, 473 MDD). Controls had either high levels of stress (Mexican-American controls were primarily recent immi- grants) or high stress levels were given higher weights in our analysis (European-ancestry controls stress levels were accessed by questionnaires). Genome-wide association study (GWAS) and rare variant (regression- and permutation-based kernel-based adaptive cluster, KBAC) analyses were performed. Whole-genome sequencing and analyses were obtained in small subset of both cohorts. Pathway and network analyses were performed. Brain expression quantitative trait loci (eQTL) were extracted from the UK Brain Expression Consortium (UKBEC), and an animal model of chronic restraint stress was used to obtain behavioral, quantitative RT-PCR and Western blot data.Results: In the Mexican-American cohort, we identified 44 common and rare functional variants associated to mild to moderate MDD. Pathway analysis disclosed that over- represented gene ontology processes included innate im- mune response, glutamate receptor signalling and detection of smell sensory perception. We replicated the PHF21B gene in the ethnically unrelated European-ancestry cohort. PHF21B variants contributed significantly to the levels of expression of this gene in the hippocampus and other brain areas. We will present new animal behavioral, molecular biology and biochemical data showing decreased hippocampal Phf21b gene and PHF21B protein express- ion in depressive-like behavior induced by chronic restraint stress.",
author = "Julio Licinio and Mauricio Arcos-Burgos and Sha Liu and Jorge Velez and Baune, {Bernhard T.} and Jawahar, {M. C.} and Volker Arolt and U. Dannlowski and Aaron Chuah and Huttley, {Gavin A.} and Rhys Fogarty and Martin Lewis and Stefan Bornstein and Ma-Li Wong",
year = "2017",
month = "11",
day = "1",
language = "English",
pages = "S549",
note = "American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting ; Conference date: 03-12-2017 Through 07-12-2017",
url = "https://www.emedevents.com/c/medical-conferences-2017/american-college-of-neuropsychopharmacology-acnp-56th-annual-meeting",

}

Licinio, J, Arcos-Burgos, M, Liu, S, Velez, J, Baune, BT, Jawahar, MC, Arolt, V, Dannlowski, U, Chuah, A, Huttley, GA, Fogarty, R, Lewis, M, Bornstein, S & Wong, M-L 2017, 'Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents' American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Desert, United States, 3/12/17 - 7/12/17, pp. S549.

Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents. / Licinio, Julio; Arcos-Burgos, Mauricio; Liu, Sha; Velez, Jorge; Baune, Bernhard T.; Jawahar, M. C.; Arolt, Volker; Dannlowski, U.; Chuah, Aaron; Huttley, Gavin A.; Fogarty, Rhys; Lewis, Martin; Bornstein, Stefan; Wong, Ma-Li.

2017. S549 Poster session presented at American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Desert, United States.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents

AU - Licinio, Julio

AU - Arcos-Burgos, Mauricio

AU - Liu, Sha

AU - Velez, Jorge

AU - Baune, Bernhard T.

AU - Jawahar, M. C.

AU - Arolt, Volker

AU - Dannlowski, U.

AU - Chuah, Aaron

AU - Huttley, Gavin A.

AU - Fogarty, Rhys

AU - Lewis, Martin

AU - Bornstein, Stefan

AU - Wong, Ma-Li

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Background: Major depressive disorder (MDD) is a gene-environment disorder that affects approximately 350 million people worldwide. However, its under- lying genetic basis remains largely unknown. In this study, we investigated the role of functional genetic variants in MDD.Methods: Whole-genome screening of functional variants were investigated in two cohorts: A discovery Los Angeles Mexican-American cohort (196 controls, 203 MDD) and a replication European-ancestry cohort (499 controls, 473 MDD). Controls had either high levels of stress (Mexican-American controls were primarily recent immi- grants) or high stress levels were given higher weights in our analysis (European-ancestry controls stress levels were accessed by questionnaires). Genome-wide association study (GWAS) and rare variant (regression- and permutation-based kernel-based adaptive cluster, KBAC) analyses were performed. Whole-genome sequencing and analyses were obtained in small subset of both cohorts. Pathway and network analyses were performed. Brain expression quantitative trait loci (eQTL) were extracted from the UK Brain Expression Consortium (UKBEC), and an animal model of chronic restraint stress was used to obtain behavioral, quantitative RT-PCR and Western blot data.Results: In the Mexican-American cohort, we identified 44 common and rare functional variants associated to mild to moderate MDD. Pathway analysis disclosed that over- represented gene ontology processes included innate im- mune response, glutamate receptor signalling and detection of smell sensory perception. We replicated the PHF21B gene in the ethnically unrelated European-ancestry cohort. PHF21B variants contributed significantly to the levels of expression of this gene in the hippocampus and other brain areas. We will present new animal behavioral, molecular biology and biochemical data showing decreased hippocampal Phf21b gene and PHF21B protein express- ion in depressive-like behavior induced by chronic restraint stress.

AB - Background: Major depressive disorder (MDD) is a gene-environment disorder that affects approximately 350 million people worldwide. However, its under- lying genetic basis remains largely unknown. In this study, we investigated the role of functional genetic variants in MDD.Methods: Whole-genome screening of functional variants were investigated in two cohorts: A discovery Los Angeles Mexican-American cohort (196 controls, 203 MDD) and a replication European-ancestry cohort (499 controls, 473 MDD). Controls had either high levels of stress (Mexican-American controls were primarily recent immi- grants) or high stress levels were given higher weights in our analysis (European-ancestry controls stress levels were accessed by questionnaires). Genome-wide association study (GWAS) and rare variant (regression- and permutation-based kernel-based adaptive cluster, KBAC) analyses were performed. Whole-genome sequencing and analyses were obtained in small subset of both cohorts. Pathway and network analyses were performed. Brain expression quantitative trait loci (eQTL) were extracted from the UK Brain Expression Consortium (UKBEC), and an animal model of chronic restraint stress was used to obtain behavioral, quantitative RT-PCR and Western blot data.Results: In the Mexican-American cohort, we identified 44 common and rare functional variants associated to mild to moderate MDD. Pathway analysis disclosed that over- represented gene ontology processes included innate im- mune response, glutamate receptor signalling and detection of smell sensory perception. We replicated the PHF21B gene in the ethnically unrelated European-ancestry cohort. PHF21B variants contributed significantly to the levels of expression of this gene in the hippocampus and other brain areas. We will present new animal behavioral, molecular biology and biochemical data showing decreased hippocampal Phf21b gene and PHF21B protein express- ion in depressive-like behavior induced by chronic restraint stress.

UR - https://www.nature.com/articles/npp2017266

M3 - Poster

SP - S549

ER -

Licinio J, Arcos-Burgos M, Liu S, Velez J, Baune BT, Jawahar MC et al. Major Depression is Associated with Rare Variants in the PHF21B Gene, a Modulator of the Stress Response in Rodents. 2017. Poster session presented at American College of Neuropsychopharmacology (ACNP) 56th Annual Meeting, Palm Desert, United States.